Clark Capital Management Group, Inc. Abb Vie Inc. Transaction History
Clark Capital Management Group, Inc.
- $13.4 Billion
- Q1 2025
A detailed history of Clark Capital Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 571,720 shares of ABBV stock, worth $107 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
571,720
Previous 3,902
14551.97%
Holding current value
$107 Million
Previous $693,000
17185.14%
% of portfolio
0.89%
Previous 0.01%
Shares
34 transactions
Others Institutions Holding ABBV
# of Institutions
4,264Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.5 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.3 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.71 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $331B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...